HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury.

Abstract
Mammalian cardiomyocytes may withstand prolonged periods of ischaemia, only to die on reperfusion. We review data that implicate mitochondrial dysfunction as a basis for reperfusion induced cell injury, and present some new evidence that suggests that such a mechanism operates in intact cardiomyocytes. The mitochondrial dysfunction is the consequence of the opening of high conductance pores in the inner mitochondrial membrane, which uncouple mitochondrial oxidative phosphorylation, promoting ATP hydrolysis. The conditions required to open the pores correlate closely to conditions that prevail upon reperfusion of the ischaemic heart: a high [Ca2+]i and Pi, low [ATP], and oxidative stress. Pore opening is suppressed by physiological concentrations of ATP. Pore opening may be prevented by cyclosporin A. Studies in isolated myocytes show that mitochondria become uncoupled after reoxygenation, and that this is associated with the hypercontracture that signals cell death. Cyclosporin A reduces the proportion of hypercontracted myocytes in populations of cells rendered anoxic.
AuthorsM R Duchen, O McGuinness, L A Brown, M Crompton
JournalCardiovascular research (Cardiovasc Res) Vol. 27 Issue 10 Pg. 1790-4 (Oct 1993) ISSN: 0008-6363 [Print] England
PMID8275525 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclosporine
  • Adenosine Triphosphate
  • Calcium
Topics
  • Adenosine Triphosphate (metabolism)
  • Animals
  • Calcium (metabolism)
  • Cyclosporine (pharmacology)
  • Intracellular Membranes (metabolism)
  • Mitochondria, Heart (drug effects, metabolism)
  • Myocardial Reperfusion Injury (metabolism)
  • Myocardium (cytology)
  • Oxidative Phosphorylation
  • Rabbits
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: